Mednow Announces Strategic Investment in US Virtual Care Provider Doko Medical Inc.
Doko Medical is a virtual healthcare provider operating across the United States (U.S.). Currently servicing 38 states, Doko Medical has over 100 physicians and health care workers engaged over its platform
Mednow Inc., Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has closed a C$500,000 investment in Doko Medical Inc. by way of convertible debenture, for a 2.8% equity interest in Doko Medical at a C$17.5M pre-money valuation.
“Given the sensitive and underserved market to support patients with erectile dysfunction, coupled with a lack of insurance coverage in the United States, we believe this investment will show our commitment to the importance of men’s health and wellness”
Doko Investment Highlights
Strategic highlights of the Doko Investment are as follows:
- Pathway to U.S. telemedicine market: the market for telemedicine in the U.S. is expected to reach US$64B by 2025, growing 18% per year1;
- Expertise in behavioral health: the behavioral health market is expected to increase to US$242B by 2027, growing 5% annually2, and Doko Medical currently has offerings in mental health and erectile dysfunction services;
- Geographic reach across the U.S.: Doko Medical currently operates in 38 states, with plans to obtain national coverage by the end of the fourth quarter of 2021;
- Established infrastructure: Doko Medical’s current service coverage includes COVID-19 tests, prescription medications, mental health support by qualified physicians, sick notes, referrals, and video visits;
- Platform to leverage pharmacy expertise: with Doko Medical focused on growing its digital healthcare operation, Mednow can contribute its pharmacy industry knowledge and technological resources to advance growth in the pharmacy channel for both companies.
Recommended AI News: Napatech Addresses Escalating Cybercrime Trends With Innovations In SmartNIC Traffic Classification
Doko Medical is a virtual healthcare provider operating across the United States (U.S.). Currently servicing 38 states, Doko Medical has over 100 physicians and health care workers engaged over its platform, which specializes in urgent care, mental health and erectile dysfunction. Doko Medical’s platform is used daily by physicians and patients, and patients can order prescriptions and send them directly to a pharmacy of choice, resulting in a hassle-free patient experience. The proceeds of the Doko investment will be used by Doko Medical to invest in digital marketing, hire U.S. sales and management staff, hire care-navigation professionals to manage patient care, and invest in a technological platform.
“Mednow’s initial investment in Doko Medical aligns with our goals of providing exceptional quality service and discrete, fast and convenient support to patients through digital pharmacies. This investment initiates Mednow’s entry into the U.S. telemedicine and pharmacy services in a prudent manner where we have the ability to benefit from the growing demands of these industries, with the option to increase our investment in the future” said Karim Nassar, Chief Executive Officer of Mednow. “Given the sensitive and underserved market to support patients with erectile dysfunction, coupled with a lack of insurance coverage in the United States, we believe this investment will show our commitment to the importance of men’s health and wellness”.
Recommended AI News: VOICE 2021 Returns In-Person with Focus on Customer Experience (CX)
From start to finish, Doko Medical will match each patient with a physician, provide the required medications, and most importantly, offer ongoing support with one of their experienced pharmacists. Currently Mednow’s online services, both on our website and our app, support men’s health in Canada, providing physician care and treatments for erectile dysfunction and male balding with free delivery.
The investment in Doko Medical further emphasizes Mednow’s support for patient care, as it lines up with recent investments in virtual doctor services, mental health, genetic testing technology and specialty pharmacy. The Doko Medical investment compliments the acquisitions of Infusicare Canada Inc. and Medvisit, which combined had aggregate revenue and gross profit in their last fiscal year of approximately C$13M and C$1.2M respectively.
“We are excited to join forces with a healthcare leader like Mednow, as we continue to strive to become a truly holistic patient care platform. Servicing our patients in an ethical, comprehensive manner is our mission and a partnership with Mednow further reinforces that journey” said Vino Shan, Founder and Chief Technology Officer of Doko Medical.
Recommended AI News: EchoX.app Launches “The METASENS Universe” Project, Rocket To The Moon
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.